SecBot SecBot
SECBOTREPLAY Home › Report › ARQT

ARQT · Two insiders at Arcutis Biotherapeutics sold a combined $170K in…

Arcutis Biotherapeutics, Inc. · CLUSTER filed Aug 21, 2026 at 16:08 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 21, 2026 at 16:08 ET

Two insiders at Arcutis Biotherapeutics sold a combined $170K in open-market sales over a week. Director Welgus Howard G. also exercised multiple derivative tranches for a net cash outlay of ~$32K, then sold the resulting shares at market prices. The total dollar value is only ~0.005% of ARQT's $3.2B market cap, making this a trivial cluster by proportionality standards. The sales are likely liquidity-driven following option exercises, not a bearish signal on the company's fundamentals.

  • Two insiders sold a total of $170K in open-market sales over 7 days.
  • Director Welgus Howard G. exercised 8,192 derivative shares (cash outlay ~$32K) and sold 4,730 shares at $26.18 for $124K.
  • Total sales represent ~0.005% of ARQT's $3.2B market cap, immaterial by academic proportionality thresholds.
  • No C-suite executives participated in the selling; the cluster is limited to a director and a 'See Remarks' officer.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access